文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

前列腺癌超低分次与常规分次放疗中阴茎根部结构与勃起功能障碍的剂量效应

Erectile Dysfunction and Absorbed Dose to Penile Base Structures in a Randomized Trial Comparing Ultrahypofractionated and Conventionally Fractionated Radiation Therapy for Prostate Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2020-01-28

本研究基于HYPO-RT-PC随机试验中673例基线勃起功能足够且放疗数据完整的患者,比较超低分次(UHF,7×6.1 Gy)与常规分次(CF,39×2.0 Gy)放疗后勃起功能障碍(ED)与阴茎球部(PB)剂量的关系。中位随访5年,两组严重ED(EDs)发生率均为27%,无显著差异;年龄是EDs最强预测因子,其次为PB剂量。作者建议将PB的D2%<50 Gy3和Dmean<20 Gy3作为放疗计划的主要目标。

要点

  • UHF与CF组严重ED发生率均为27%,两组间无显著差异。
  • 年龄是严重ED最强预测因子,PB剂量次之,年轻患者中更明显。
  • 建议计划目标:PB的D2%<50 Gy3且Dmean<20 Gy3。

核心结论

  • CF与UHF组严重ED发生率相似,年龄是最强预测因子,其次为阴茎球部剂量。
  • 建议将阴茎球部D2%<50 Gy3和Dmean<20 Gy3作为放疗计划的主要目标。

研究设计与样本

  • 基于HYPO-RT-PC随机试验的剂量效应研究,纳入673例(占1180例符合方案患者的57%)基线勃起功能足够且放疗数据完整的前列腺癌患者。
  • 患者随机接受CF(39×2.0 Gy,8周)或UHF(7×6.1 Gy,2.5周),不允许使用雄激素剥夺治疗,中位随访5年。
  • 回顾性勾画阴茎球部(PB)和阴茎脚,从EQD2转换剂量矩阵(α/β=3 Gy)衍生剂量体积参数,采用Cox和logistic回归分析预测因子。

主要发现

  • 随访期间CF和UHF组严重ED发生率均为27%,两组间无显著差异。
  • PB平均剂量中位数:CF组24.5(20.2)Gy3,UHF组18.7(13.1)Gy3。
  • Cox分析中年龄是严重ED唯一显著预测因子;单因素logistic回归中所有剂量体积参数在2年随访时均显著。
  • 多因素logistic回归中,年龄和近最大剂量(D2%)在1年和2年均为严重ED显著预测因子。

关键数值与推荐

  • 建议阴茎球部D2%<50 Gy3且Dmean<20 Gy3作为放疗计划主要目标。
  • 严重ED定义为主要终点,由医生在定期随访中评估。

临床怎么用

  • 在前列腺癌放疗计划中应关注阴茎球部剂量,尽量满足D2%<50 Gy3和Dmean<20 Gy3。
  • 年轻患者放疗后严重ED风险更高,计划优化时应优先考虑阴茎球部剂量约束。

局限性

  • 仅纳入基线勃起功能足够且放疗数据完整的患者(673/1180,57%),可能存在选择偏倚。
  • 阴茎球部和阴茎脚为回顾性勾画,剂量体积参数基于EQD2转换(α/β=3 Gy)。
  • 严重ED由医生评估,非患者自报量表。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To study the relationships between absorbed dose to penile base structures and erectile dysfunction (ED) in patients treated with ultrahypofractionated (UHF) radiation therapy (RT) or conventionally fractionated (CF) RT for prostate cancer. METHODS AND MATERIALS: This dose-response study comprises 673 patients (57%) of the 1180 per-protocol patients included in the HYPO-RT-PC trial (median follow-up 5, years), where patients were randomized to CF (39 × 2.0 Gy, 8 weeks) or UHF (7 × 6.1 Gy, 2.5 weeks). No androgen deprivation therapy was allowed. Only patients with erectile function sufficient for intercourse at baseline and complete RT data were included in this study. Erectile function was assessed by physician at regular follow-ups. The main endpoint was severe ED (EDs). The penile bulb (PB) and crus were retrospectively delineated on the treatment planning computed tomography scans. Dose-volume descriptors were derived from EQD2 converted dose matrices (α/β = 3 Gy). Univariable and multivariable Cox proportional hazard regression and logistic regression were used to find predictors for EDS. RESULTS: No significant difference in EDs was found between CF and UHF. During the follow-up period, EDs occurred in 27% of the patients in both treatment groups. Average (median) PB mean dose, Dmean, was 24.5 (20.2) in CF and 18.7 (13.1) Gy3 in UHF. Age was the only significant predictor for EDs in Cox analyses. All dose-volume variables contributed significantly in univariable logistic regression at 2-year follow-up. Age and near maximum dose (D2%) were significant predictors for EDs in multivariable logistic regression analyses at both 1 and 2 years. CONCLUSIONS: The frequency of EDS was similar in the CF and UHF treatment groups. Age at radiation therapy was the strongest predictor for EDs, followed by dose to PB, and was most evident for younger patients. We propose D2 % <50 Gy3 and Dmean <20 Gy3 to the PB as the primary objectives to be applied in the treatment planning process.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Rasmusson E, Gunnlaugsson A, Wieslander E, et al. Erectile Dysfunction and Absorbed Dose to Penile Base Structures in a Randomized Trial Comparing Ultrahypofractionated and Conventionally Fractionated Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2020. PMID: 32004582. doi:10.1016/j.ijrobp.2020.01.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。